# A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

> clinical trial · VERIFIED · 2026-08-05

Status: RECRUITING · Sponsor: Daiichi Sankyo · Condition: Small Cell Lung Cancer

- Company: Daiichi Sankyo
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06203210

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.